Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry

Yazar
Ozatilgan, Ayse
Ozguroglut, Mustafa
Ecstein-Fraisse, Evelyne B.
Karavasilis, Vasilios
Hitler, Simon
Silva, Alberto
Akaza, Hideyuki
Procopio, Giuseppe
Pripatnanont, Choosak
Facchini, Gaetano
Fava, Sergio
Wheatley, Duncan
Leung, Kwong Chuen
Butt, Mohammad
Castillo, Liliana
Üst veri
Tüm öğe kaydını göster
Özet
Purpose There is a major clinical need to devise an optimal treatment sequence for the multiple therapy options available for patients with metastatic castration-resistant prostate cancer (mCRPC). In the absence of prospective clinical trials, sequencing information can be derived from large, real-world registry studies.
Bağlantı
http://hdl.handle.net/20.500.12627/93867
https://doi.org/10.1200/jgo.18.00009
Koleksiyonlar